Free Account Opening + AMC Free Demat
Loading...

Emami Limited Buyback 2023 vs Natco Pharma Buyback 2023

Comparision between Emami Limited Buyback 2023 and Natco Pharma Buyback 2023.

Buyback Details

Emami Limited Buyback 2023 is a Open Market Through Stock Exchange buyback proposed to list at BSE, NSE while Natco Pharma Buyback 2023 is a Open Market Through Stock Exchange proposed to list at BSE, NSE.

  Emami Limited Natco Pharma Limited
Logo Emami Limited Buyback 2023 Logo Natco Pharma Buyback 2023 Logo
Type of Buyback Open Market Through Stock Exchange Open Market Through Stock Exchange
Listing At BSE, NSE BSE, NSE
Face Value ₹1 per share ₹2 per share
Buyback Price ₹450 per share ₹700 per share
Issue Size
Issue Size (Amount) ₹186.00 Crores ₹210.00 Crores
Buyback Ratio
Registrar Maheshwari Datamatics Pvt. Ltd Venture Capital And Corporate Investments Pvt Ltd
Lead Managers Iifl Securities Ltd Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd)
Necessity of the buyback

The Buyback aims to:
i) Return surplus cash to its Shareholders.
ii) Reduce the outstanding number of equity shares and consequently increase earnings per share and book value per share.
iii) Improve key return ratios like return on equity capital.

The Buyback is being undertaken for the following reasons:

  1. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares
  2. The Buyback may help in improving return on equity, by the reduction in the equity base.
  3. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.

Buyback Timetable

Emami Limited Buyback 2023 and Natco Pharma Buyback 2023 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Emami Limited Buyback 2023 Buyback record date is . Natco Pharma Buyback 2023 Buyback record date is .

  Emami Limited Natco Pharma Limited
Record Date
Offer Open Date Apr 13, 2023 Mar 21, 2023
Offer Closure Date Jul 06, 2023 May 12, 2023
Last date for receipt of tender forms
Finalisation of buyback
Last Date for settlment of bids
Last Date for extinguishment of shares

Financial Details and Other Relevent Information

Comparison of Emami Limited Buyback 2023 and Natco Pharma Buyback 2023 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Emami Limited Natco Pharma Limited
Financial
Emami Limited Financial Information (Restated Consolidated)
Period EndedTotal RevenueProfit After TaxNet Worth
31-Mar-202,711.95302.301,823.75
31-Mar-212,950.80454.711,762.65
31-Mar-223,287.28836.672,076.59
Amount in ₹ Crore
Natco Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal RevenueProfit After TaxNet Worth
31-Mar-202,022.40458.103,773.50
31-Mar-212,155.70442.404,121.60
31-Mar-222,043.80170.004,263.60
31-Dec-221,884.80439.504,628.20
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 443.00 374.90 399.73
Jan-2023 449.20 414.45 430.35
Dec-2022 480.05 408.20 445.89

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 554.95 502.00 535.04
Jan-2023 570.40 526.00 545.28
Dec-2022 599.00 548.00 565.78
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 443.20 374.80 400.08
Jan-2023 440.80 414.00 429.56
Dec-2022 481.00 410.00 441.93

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 555.00 502.00 534.88
Jan-2023 570.00 526.10 545.36
Dec-2022 600.00 547.50 565.78

Comments

Add a public comment...